Wenting Xu

2.0k total citations · 1 hit paper
46 papers, 1.6k citations indexed

About

Wenting Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenting Xu has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Wenting Xu's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Ovarian function and disorders (5 papers) and Cancer Cells and Metastasis (4 papers). Wenting Xu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Ovarian function and disorders (5 papers) and Cancer Cells and Metastasis (4 papers). Wenting Xu collaborates with scholars based in China, South Korea and United States. Wenting Xu's co-authors include Zhen Yang, Nonghua Lü, Tingting Tang, Zhenyu Bian, Qiming Fan, Gang Li, Lihong Wang, Mi‐Kyung Lee, Eun Ju Bae and Mengyu Tang and has published in prestigious journals such as Scientific Reports, Cancer Letters and Medical Physics.

In The Last Decade

Wenting Xu

44 papers receiving 1.6k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

2015 493 citations Wenting Xu, Zhen Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenting Xu China	18	872	424	412	206	168	46	1.6k
Jianghong Wu China	23	901 1.0×	317 0.7×	379 0.9×	193 0.9×	180 1.1×	49	1.6k
Hua You China	23	605 0.7×	313 0.7×	282 0.7×	233 1.1×	262 1.6×	70	1.5k
Federica Papaccio Italy	21	1.0k 1.2×	909 2.1×	594 1.4×	293 1.4×	185 1.1×	42	2.0k
Xia Zhao China	22	814 0.9×	293 0.7×	218 0.5×	125 0.6×	273 1.6×	99	1.5k
Rong Shao China	21	981 1.1×	730 1.7×	463 1.1×	255 1.2×	206 1.2×	58	2.3k
Ye Cheng China	19	1.2k 1.4×	283 0.7×	650 1.6×	262 1.3×	275 1.6×	59	2.1k
Hongming Zhu China	25	1.3k 1.5×	525 1.2×	434 1.1×	83 0.4×	184 1.1×	59	2.1k
Xinxin Zhang China	18	684 0.8×	517 1.2×	318 0.8×	436 2.1×	229 1.4×	76	1.5k
Yuhua Li China	24	861 1.0×	641 1.5×	367 0.9×	145 0.7×	244 1.5×	88	1.7k
Masanobu Tsubaki Japan	31	1.2k 1.3×	848 2.0×	660 1.6×	206 1.0×	194 1.2×	93	2.2k

Countries citing papers authored by Wenting Xu

Since Specialization

Citations

This map shows the geographic impact of Wenting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenting Xu more than expected).

Fields of papers citing papers by Wenting Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenting Xu. The network helps show where Wenting Xu may publish in the future.

Co-authorship network of co-authors of Wenting Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenting Xu. A scholar is included among the top collaborators of Wenting Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenting Xu. Wenting Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Li & Wenting Xu. (2025). A disproportionality analysis of FDA adverse event reporting system events for misoprostol. Scientific Reports. 15(1). 2452–2452. 1 indexed citations

Zhou, Enze, Wenjian Li, Wenting Xu, et al.. (2025). STEPC: A Pixel-wise Nonuniformity Correction Framework for Photon-Counting CT in Multi-material Imaging Scenarios. ArXiv.org.

Zhou, Zeyu, et al.. (2025). Circulating microRNA-1 as a diagnostic biomarker for acute myocardial infarction: a meta-analysis. Cardiology Journal. 32(6). 643–654. 1 indexed citations

Zhang, Wenbo, Zhen Liu, Xinyu Qian, et al.. (2024). PBMC-mediated modulation of macrophage polarization in RAW264.7 cells through STAT1/STAT6 signaling cascades. International Immunopharmacology. 138. 112651–112651. 4 indexed citations

Xu, Wenting, et al.. (2023). CT‐based radiomics prediction of CXCL13 expression in ovarian cancer. Medical Physics. 50(11). 6801–6814. 5 indexed citations

Xu, Wenting, et al.. (2021). Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial. Trials. 22(1). 781–781. 6 indexed citations

Wang, Congcong, Jianping Guo, Xiaoyang Zhao, et al.. (2021). Identification of Hub Genes in Pancreatic Ductal Adenocarci-noma Using Bioinformatics Analysis. Iranian Journal of Public Health. 50(11). 2238–2245. 3 indexed citations

Zhao, Rongrong, Wenting Xu, Le Huu Song, et al.. (2020). Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1‐mediated DNA methylation mechanism. Cancer Medicine. 9(7). 2551–2563. 24 indexed citations

Xu, Wenting, Jason S. Rush, Daniel B. Graham, Zhifang Cao, & Ramnik J. Xavier. (2020). USP15 Deubiquitinates CARD9 to Downregulate C-Type Lectin Receptor–Mediated Signaling. ImmunoHorizons. 4(10). 670–678. 7 indexed citations

10.

Xu, Wenting, et al.. (2020). Anti-inflammatory activities of puerarin in high-fat diet-fed rats with streptozotocin-induced gestational diabetes mellitus. Molecular Biology Reports. 47(10). 7537–7546. 34 indexed citations

11.

Zhong, Xinglong, Zehua Li, Dongjian Huang, et al.. (2020). Puerarin Alleviates Lipopolysaccharide-Induced Myocardial Fibrosis by Inhibiting PARP-1 to Prevent HMGB1-Mediated TLR4-NF-κB Signaling Pathway. Cardiovascular Toxicology. 20(5). 482–491. 38 indexed citations

12.

Xu, Wenting, Eun Ju Bae, & Mi‐Kyung Lee. (2018). Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells. International Journal of Nanomedicine. Volume 13. 7549–7563. 61 indexed citations

13.

Xu, Wenting, Licht Miyamoto, Naonobu Tanaka, et al.. (2018). Methanol extraction fraction from Citrus Sudachi peel exerts lipid reducing effects in cultured cells. The Journal of Medical Investigation. 65(3.4). 225–230. 7 indexed citations

14.

Yang, Zhen, Wenting Xu, Chuan Xie, et al.. (2017). Phosphorylation of phosphatase and tensin homolog induced by Helicobacter pylori promotes cell invasion by activation of focal adhesion kinase. Oncology Letters. 15(1). 1051–1057. 4 indexed citations

15.

Xu, Wenting, Zhen Yang, & Nonghua Lü. (2016). Molecular targeted therapy for the treatment of gastric cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 1–1. 233 indexed citations

16.

Xu, Wenting, Zhen Yang, & Nonghua Lü. (2016). From pathogenesis to clinical application: insights into exosomes as transfer vectors in cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 156–156. 40 indexed citations

17.

Xu, Wenting, Yingjie Jia, Xiaojiang Li, & Jun Chen. (2015). [MicroRNAs and prostate cancer].. PubMed. 21(5). 458–62. 1 indexed citations

18.

Wang, Lihong, Xu Wang, Wenting Xu, & Yali Hu. (2013). MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis. Tumor Biology. 35(4). 3167–3170. 8 indexed citations

19.

Xu, Wenting, et al.. (2011). Combination of Curcumin and Paclitaxel-loaded Solid Lipid Nanoparticles to Overcome Multidrug Resistance. Journal of Pharmaceutical Investigation. 41(6). 381–386. 3 indexed citations

20.

Bian, Zhenyu, Gang Li, Yaokai Gan, et al.. (2009). Increased Number of Mesenchymal Stem Cell-like Cells in Peripheral Blood of Patients with Bone Sarcomas. Archives of Medical Research. 40(3). 163–168. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact